S
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Price:
28.42 CNY
0.25%
Market Closed
Updated:
May 15, 2024
Shandong Pharmaceutical Glass Co Ltd
Cost of Revenue
|
Shandong Pharmaceutical Glass Co Ltd
Cost of Revenue Peer Comparison
Comparables:
1066
603658
300888
300832
300595
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Cost of Revenue
-¥3.6B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-13%
|
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Cost of Revenue
-¥6.6B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Cost of Revenue
-¥1.6B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Winner Medical Co Ltd
SZSE:300888
|
Cost of Revenue
-¥4.4B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Cost of Revenue
-¥1.1B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
Autek China Inc
SZSE:300595
|
Cost of Revenue
-¥477.9m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
See Also
What is Shandong Pharmaceutical Glass Co Ltd's Cost of Revenue?
Cost of Revenue
-3.6B
CNY
-3.6B
CNY
Based on the financial report for Sep 30, 2023, Shandong Pharmaceutical Glass Co Ltd's Cost of Revenue amounts to -3.6B CNY.
What is Shandong Pharmaceutical Glass Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-13%
-13%
Over the last year, the Cost of Revenue growth was -23%. The average annual Cost of Revenue growth rates for Shandong Pharmaceutical Glass Co Ltd have been -22% over the past three years , -16% over the past five years , and -13% over the past ten years .
You don't have any saved screeners yet
